These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 2458825)
41. Difference in tissue expression of tumour markers CA 19-9 and CA 50 in hepatocellular carcinoma and cholangiocarcinoma. Haglund C; Lindgren J; Roberts PJ; Nordling S Br J Cancer; 1991 Mar; 63(3):386-9. PubMed ID: 1848439 [TBL] [Abstract][Full Text] [Related]
42. Alpha fetoprotein and carcinoembryonic antigen producing hepatocellular carcinoma. A case report studied by immunohistochemistry. Amano S; Kataoka H; Hazama F; Nakatake M; Maki A Acta Pathol Jpn; 1985 Jul; 35(4):969-74. PubMed ID: 2416187 [TBL] [Abstract][Full Text] [Related]
43. HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates. Wang L; Vuolo M; Suhrland MJ; Schlesinger K Acta Cytol; 2006; 50(3):257-62. PubMed ID: 16780018 [TBL] [Abstract][Full Text] [Related]
44. Hepatocellular carcinoma versus carcinoma metastatic to the liver. Value of stains for carcinoembryonic antigen and naphthylamidase in fine needle aspiration biopsy material. Wong MA; Yazdi HM Acta Cytol; 1990; 34(2):192-6. PubMed ID: 2157322 [TBL] [Abstract][Full Text] [Related]
45. Distribution of five antigens in hepatocellular carcinoma. Thung SN; Gerber MA; Sarno E; Popper H Lab Invest; 1979 Aug; 41(2):101-5. PubMed ID: 88543 [TBL] [Abstract][Full Text] [Related]
46. [Alpha-1-fetoprotein in tumour tissue (author's transl)]. Wilke H; Harms D Dtsch Med Wochenschr; 1979 Oct; 104(43):1527-9. PubMed ID: 91477 [TBL] [Abstract][Full Text] [Related]
47. [Cellular localization of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG), and carcinoembryonic antigen (CEA) in malignant germ cell tumors of the ovary using immunoperoxidase technique (author's transl)]. Obata N; Kodama S; Hando T; Takeuchi S Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):757-66. PubMed ID: 6165791 [TBL] [Abstract][Full Text] [Related]
48. Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma. Röcken C; Licht J; Roessner A; Carl-McGrath S J Clin Pathol; 2005 Oct; 58(10):1069-75. PubMed ID: 16189153 [TBL] [Abstract][Full Text] [Related]
49. Phenotypic characterization of hepatic proliferation. Antigenic expression by proliferating epithelial cells in fetal liver, massive hepatic necrosis, and nodular transformation of the liver. Gerber MA; Thung SN; Shen S; Stromeyer FW; Ishak KG Am J Pathol; 1983 Jan; 110(1):70-4. PubMed ID: 6185004 [TBL] [Abstract][Full Text] [Related]
50. [Immunohistochemical studies in hepatocarcinomas]. Delfino MI; De Marco L; Simian S; Avagnina A; Elsner B Medicina (B Aires); 1985; 45(3):235-9. PubMed ID: 2429135 [No Abstract] [Full Text] [Related]
51. Hepatoid adenocarcinomas of the stomach. An analysis of seven cases. Ishikura H; Kirimoto K; Shamoto M; Miyamoto Y; Yamagiwa H; Itoh T; Aizawa M Cancer; 1986 Jul; 58(1):119-26. PubMed ID: 2423220 [TBL] [Abstract][Full Text] [Related]
52. [Nonspecific tumor markers in hepatocellular carcinoma]. Stanciu L; Dumitraşcu D; Radu D; Badea R; Petcovici M; Ioniţă A; Szabo P; Pascu O Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(5):443-9. PubMed ID: 2473509 [No Abstract] [Full Text] [Related]
53. Alpha-fetoprotein (AFP) elevation gastric adenocarcinoma and importance of AFP change in tumor response evaluation. Tatli AM; Urakci Z; Kalender ME; Arslan H; Tastekin D; Kaplan MA Asian Pac J Cancer Prev; 2015; 16(5):2003-7. PubMed ID: 25773802 [TBL] [Abstract][Full Text] [Related]
54. Immunohistochemical type distinction of alpha-fetoprotein in various alpha-fetoprotein-secreting tumors. Okamoto T; Hirabayashi K; Ishiguro T Jpn J Cancer Res; 1993 Apr; 84(4):360-4. PubMed ID: 7685750 [TBL] [Abstract][Full Text] [Related]
55. Immunohistochemistry of hepatocellular carcinoma associated with cirrhosis. Espinoza CG; Pillarisetti SG; Azar HA Ann Clin Lab Sci; 1984; 14(6):467-73. PubMed ID: 6210034 [TBL] [Abstract][Full Text] [Related]
56. Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma. Pitman MB; Triratanachat S; Young RH; Oliva E Int J Gynecol Pathol; 2004 Jan; 23(1):58-64. PubMed ID: 14668552 [TBL] [Abstract][Full Text] [Related]
57. The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas. Stroescu C; Herlea V; Dragnea A; Popescu I J Gastrointestin Liver Dis; 2006 Mar; 15(1):9-14. PubMed ID: 16680226 [TBL] [Abstract][Full Text] [Related]
58. Thyroxine-binding globulin as a marker of liver tumors. Terui S; Moriya Y; Yamamoto H; Koyama Y Cancer Detect Prev; 1987; 10(5-6):371-8. PubMed ID: 2436781 [TBL] [Abstract][Full Text] [Related]
59. Serum alpha-fetoprotein subfractions in patients with primary hepatoma or hepatic metastasis of gastric cancer. Ishiguro T; Sugitachi I; Sakaguchi H; Itani S Cancer; 1985 Jan; 55(1):156-9. PubMed ID: 2578079 [TBL] [Abstract][Full Text] [Related]